• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis?

作者信息

Stöllberger Claudia, Bastovansky Adam, Finsterer Josef

机构信息

2nd Medical Department, Krankenanstalt Rudolfstiftung, Steingasse 31/18, Juchgasse 25, 1030, Vienna, Österreich, Austria,

出版信息

J Thromb Thrombolysis. 2013 Nov;36(4):492-4. doi: 10.1007/s11239-013-0884-1.

DOI:10.1007/s11239-013-0884-1
PMID:23404775
Abstract
摘要

相似文献

1
Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis?
J Thromb Thrombolysis. 2013 Nov;36(4):492-4. doi: 10.1007/s11239-013-0884-1.
2
Oral anticoagulants for stroke prevention in atrial fibrillation. Foreword.用于心房颤动中风预防的口服抗凝剂。前言。
Curr Probl Cardiol. 2014 Sep;39(9):317. doi: 10.1016/j.cpcardiol.2014.07.002. Epub 2014 Jul 16.
3
Clinical Challenges of Using Novel Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.使用新型口服抗凝药预防心房颤动患者卒中的临床挑战
Tex Heart Inst J. 2018 Jun 1;45(3):164-165. doi: 10.14503/THIJ-18-6678. eCollection 2018 Jun.
4
Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?鉴于新型口服抗凝剂的新数据已经可得，当前关于预防中风的心房颤动指南是否需要更改？
Int J Clin Pract. 2012 May;66(5):422-4. doi: 10.1111/j.1742-1241.2011.02815.x.
5
The Use of Oral Anticoagulants in Patients with Atrial Fibrillation in the Emergency Department.急诊科房颤患者的口服抗凝剂应用。
J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104599. doi: 10.1016/j.jstrokecerebrovasdis.2019.104599. Epub 2020 Jan 27.
6
Blood Thinners for Atrial Fibrillation Stroke Prevention.用于预防心房颤动中风的血液稀释剂。
Circ Arrhythm Electrophysiol. 2021 Jun;14(6):e009389. doi: 10.1161/CIRCEP.120.009389. Epub 2021 Jun 11.
7
[New anticoagulants for stroke prevention in atrial fibrillation].[用于心房颤动中风预防的新型抗凝剂]
Herz. 2012 Jun;37(4):370-7. doi: 10.1007/s00059-012-3617-x.
8
Overview of the non-vitamin K oral anticoagulants for atrial fibrillation.用于心房颤动的非维生素K口服抗凝剂概述。
Ther Adv Cardiovasc Dis. 2017 Mar;11(3):77-79. doi: 10.1177/1753944717690481.
9
Current evidence for new oral anticoagulants in the treatment of nonvalvular atrial fibrillation: comparison of substudies.新型口服抗凝剂治疗非瓣膜性心房颤动的当前证据：亚组研究比较
Rev Esp Cardiol (Engl Ed). 2015 Mar;68(3):185-9. doi: 10.1016/j.rec.2014.07.016. Epub 2014 Nov 7.
10
[Possible Choice of New Oral Anticoagulants With Non-Valvular Atrial Fibrillation: a Review of Meta-Analyzes].
Kardiologiia. 2015;55(3):97-105.

本文引用的文献

1
The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation.抗栓治疗的同时使用与房颤患者出血风险。
Thromb Haemost. 2013 Mar;109(3):431-9. doi: 10.1160/TH12-08-0542. Epub 2013 Jan 10.
2
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.在不适合使用华法林的房颤患者中，使用阿司匹林与使用阿哌沙班治疗时的出血情况：在因不耐受或治疗失败而不能使用维生素 K 拮抗剂的房颤患者中，比较阿哌沙班与乙酰水杨酸预防卒中的疗效（AVERROES 试验）。
Stroke. 2012 Dec;43(12):3291-7. doi: 10.1161/STROKEAHA.112.664144. Epub 2012 Oct 2.
3
Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke.连续卒中单元心电图监测与 24 小时动态心电图 Holter 监测在检测卒中后阵发性心房颤动中的比较。
Stroke. 2012 Oct;43(10):2689-94. doi: 10.1161/STROKEAHA.112.654954. Epub 2012 Aug 7.
4
Rivaroxaban in patients with a recent acute coronary syndrome.利伐沙班用于近期急性冠状动脉综合征患者。
N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.
5
Stenting versus aggressive medical therapy for intracranial arterial stenosis.颅内动脉狭窄的血管内支架置入与积极药物治疗的比较。
N Engl J Med. 2011 Sep 15;365(11):993-1003. doi: 10.1056/NEJMoa1105335. Epub 2011 Sep 7.
6
Apixaban versus warfarin in patients with atrial fibrillation.阿哌沙班与华法林用于房颤患者。
N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.
7
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动。
N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.
8
Apixaban with antiplatelet therapy after acute coronary syndrome.急性冠脉综合征后应用阿哌沙班联合抗血小板治疗。
N Engl J Med. 2011 Aug 25;365(8):699-708. doi: 10.1056/NEJMoa1105819. Epub 2011 Jul 24.
9
Increases in cerebral atherosclerosis according to CHADS2 scores in patients with stroke with nonvalvular atrial fibrillation.根据非瓣膜性心房颤动中风患者的 CHADS2 评分，脑动脉粥样硬化增加。
Stroke. 2011 Apr;42(4):930-4. doi: 10.1161/STROKEAHA.110.602987. Epub 2011 Feb 24.
10
Dabigatran versus warfarin in patients with atrial fibrillation.达比加群与华法林用于房颤患者的比较。
N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30.